Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8551-8600 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05306028
Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)
PHASE2Active, not recruiting
20 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05463900
Microbial and Human Determinants of the Onset of IBD Flares
N/AActive, not recruiting
2,000 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2025
5 conditions1 sponsor1 location
NCT05351749
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NAActive, not recruiting
306 participants
Started: Aug 1, 2022 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT05544513
Oral Iron Supplementation for Patients With Chronic Kidney Disease
PHASE2Active, not recruiting
6 participants
Started: Aug 1, 2022 · Completed: Dec 30, 2026
4 conditions1 sponsor1 location
NCT05485974
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
PHASE1Active, not recruiting
44 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor14 locations
NCT05220137
Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy
NAActive, not recruiting
270 participants
Started: Aug 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor3 locations
NCT05445141
Little ACF (Lilla ABC): Evaluation of a Parental Support Program for Parents of Children Aged 1-2 Years
NAActive, not recruiting
670 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
5 conditions3 sponsors1 location
NCT05463029
Resting State fMRI in Disorders of Consciousness
N/AActive, not recruiting
70 participants
Started: Aug 1, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05784883
Tricuspid Regurgitation in the ElderlY
N/AActive, not recruiting
700 participants
Started: Aug 1, 2022 · Completed: Aug 1, 2029
1 condition1 sponsor1 location
NCT05665049
Social Transfers for Exclusive Breastfeeding
NAActive, not recruiting
300 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2027
4 conditions4 sponsors1 location
NCT05413733
Neuropsychological Rehabilitation Over the Internet
NAActive, not recruiting
150 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT05445518
Jump Start Plus COVID-19 Support
NAActive, not recruiting
1,200 participants
Started: Aug 1, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05300737
Symptomatic Carotid Outcomes Registry
N/AActive, not recruiting
114 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor18 locations
NCT05211713
Opp - a Universal Mental Health Promoting Mobile Application for Adolescents
NAActive, not recruiting
700 participants
Started: Aug 1, 2022 · Completed: Dec 1, 2030
1 condition4 sponsors1 location
NCT04039464
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
PHASE3Active, not recruiting
100 participants
Started: Aug 1, 2022 · Completed: May 30, 2026
1 condition3 sponsors10 locations
NCT05463731
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
PHASE3Active, not recruiting
1,667 participants
Started: Aug 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor76 locations
NCT05491811
Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation
PHASE2Active, not recruiting
49 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2026
1 condition15 sponsors1 location
NCT06591546
Telescoping Nail in Osteogenesis Imperfecta
NAActive, not recruiting
20 participants
Started: Aug 1, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05811897
RESILIENT : A Self-Managed Online Platform for Victims of Sexual Assault
NAActive, not recruiting
204 participants
Started: Aug 1, 2022 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT05563870
Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma
NAActive, not recruiting
30 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT05320809
Study of 3D189 in Patients With Hematologic Malignancies
PHASE1Active, not recruiting
15 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor4 locations
NCT05038228
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
N/AActive, not recruiting
1 participants
Started: Aug 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05519605
Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD
N/AActive, not recruiting
61 participants
Started: Aug 1, 2022 · Completed: Jul 1, 2024
3 conditions1 sponsor1 location
NCT06664190
Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency
N/AActive, not recruiting
200 participants
Started: Aug 1, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05566041
A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer
PHASE3Active, not recruiting
292 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06403709
Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients
PHASE2Active, not recruiting
35 participants
Started: Aug 1, 2022 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT04953130
Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania
PHASE4Active, not recruiting
10,400 participants
Started: Aug 1, 2022 · Completed: Oct 31, 2026
2 conditions6 sponsors1 location
NCT05932056
A Randomized Controlled Trial of Miles de Manos (Thousands of Hands)
NAActive, not recruiting
3,000 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05914558
Comorbid Painful TMD Among Trigeminal Neuralgia
N/AActive, not recruiting
5 participants
Started: Aug 1, 2022 · Completed: Aug 30, 2026
4 conditions2 sponsors2 locations
NCT05277831
Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention
NAActive, not recruiting
1,209 participants
Started: Aug 1, 2022 · Completed: Aug 31, 2026
6 conditions2 sponsors1 location
NCT05492396
Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant
N/AActive, not recruiting
30 participants
Started: Aug 1, 2022 · Completed: Jan 31, 2026
3 conditions1 sponsor3 locations
NCT05141019
Trial of Preemptive Pharmacogenetics in Underserved Patients
NAActive, not recruiting
492 participants
Started: Aug 1, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT07071246
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
NAActive, not recruiting
30 participants
Started: Aug 1, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05283629
nCCR for Chemotherapy Related Cognitive Impairment Randomized Study
NAActive, not recruiting
20 participants
Started: Aug 1, 2022 · Completed: Mar 1, 2029
2 conditions2 sponsors1 location
NCT05455671
Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance Tomography
N/AActive, not recruiting
110 participants
Started: Aug 1, 2022 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05375994
Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients
PHASE1/PHASE2Active, not recruiting
85 participants
Started: Aug 1, 2022 · Completed: Jan 1, 2026
6 conditions2 sponsors8 locations
NCT05458271
Cross-linked Volume-stable Collagen Matrix Versus Connective Tissue Graft At Implant Site.
NAActive, not recruiting
100 participants
Started: Jul 31, 2022 · Completed: Jun 25, 2025
2 conditions1 sponsor1 location
NCT05033756
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO
PHASE2Active, not recruiting
11 participants
Started: Jul 30, 2022 · Completed: Feb 28, 2026
2 conditions2 sponsors6 locations
NCT06154902
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
N/AActive, not recruiting
350 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05595473
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma
PHASE1/PHASE2Active, not recruiting
42 participants
Started: Jul 29, 2022 · Completed: May 31, 2029
1 condition1 sponsor5 locations
NCT05363046
Noninterventional Study Evaluating Parkinson's Disease Diary Use
N/AActive, not recruiting
194 participants
Started: Jul 29, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor34 locations
NCT05222984
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
PHASE1Active, not recruiting
17 participants
Started: Jul 29, 2022 · Completed: Apr 2, 2026
2 conditions2 sponsors1 location
NCT05457257
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
PHASE4Active, not recruiting
43 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors35 locations
NCT05420844
Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic Fibrosis
NAActive, not recruiting
30 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03999853
Butyrate Adjuvant Therapy for Type 1 Diabetes
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05167409
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
PHASE2Active, not recruiting
48 participants
Started: Jul 28, 2022 · Completed: Mar 1, 2026
1 condition6 sponsors4 locations
NCT05825508
PedBot Ankle Rehablitation
N/AActive, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Jul 28, 2025
1 condition1 sponsor1 location
NCT05233384
Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
N/AActive, not recruiting
70 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor7 locations
NCT05342519
Daily Topical Rapamycin for Vitiligo
PHASE2Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Aug 1, 2026
1 condition2 sponsors1 location
NCT06094322
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
NAActive, not recruiting
34 participants
Started: Jul 28, 2022 · Completed: Jun 9, 2025
1 condition1 sponsor1 location